The survival impact of palliative chemotherapy dose modifications on metastatic colon cancer

BACKGROUND: An uninterrupted dose of oxaliplatin-based cytotoxic therapy is an essential component in the standard treatment regimen of metastatic colon cancer (mCC). Data on the impacts of dose intensity reduction on the palliative treatment for patients with mCC remain scarce. Hence, this study ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Zainal Abidin, Mohd Naqib, Omar, Marhanis Salihah, Islahudin, Farida, Mohamed Shah, Noraida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254497/
https://www.ncbi.nlm.nih.gov/pubmed/35787795
http://dx.doi.org/10.1186/s12885-022-09831-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254497/
https://www.ncbi.nlm.nih.gov/pubmed/35787795
http://dx.doi.org/10.1186/s12885-022-09831-7

Ejemplares similares